An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial

Peer Review reports

Original Submission
16 Apr 2020	Submitted	Original manuscript
13 Jun 2020	Reviewed	Reviewer Report - Thomas Butler
17 Jun 2020	Reviewed	Reviewer Report - Alexander Gough
22 Jul 2020	Author responded	Author comments - Rindra Vatosoa Randremanana
Resubmission - Version 2
22 Jul 2020	Submitted	Manuscript version 2
Publishing
29 Jul 2020	Editorially accepted
17 Aug 2020	Article published	10.1186/s13063-020-04642-2

Back to article page